Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINOPHARM

18.840
-0.050-0.26%
Volume:3.14M
Turnover:59.19M
Market Cap:58.79B
PE:7.64
High:19.040
Open:18.840
Low:18.760
Close:18.890
Loading ...

Sinopharm Group Stock Climbs 1.0% in Hong Kong

Dow Jones
·
Yesterday

Sinopharm Group Stock Advances 1.9% in Hong Kong

Dow Jones
·
28 Jul

Sinopharm Group Stock Rallies 1.4% in Hong Kong

Dow Jones
·
24 Jul

Sinopharm Group Stock Climbs 1.6% in Hong Kong

Dow Jones
·
22 Jul

Sinopharm Group Stock Slips 1.1% in Hong Kong

Dow Jones
·
16 Jul

Morgan Stanley Downgrades SINOPHARM Target to HK$22.50, Keeps Overweight Rating

Market Watcher
·
15 Jul

Morgan Stanley Trims Sinopharm Group (01099) Target to HK$22.5, Maintains Overweight Rating

Stock Track
·
15 Jul

Sinopharm Group Stock Rises 1.6% in Hong Kong

Dow Jones
·
14 Jul

Sinopharm Group Stock Rallies 1.6% in Hong Kong

Dow Jones
·
10 Jul

There Are Reasons To Feel Uneasy About Sinopharm Group's (HKG:1099) Returns On Capital

Simply Wall St.
·
03 Jul

Sinopharm Group Stock Slides 1.4% in Hong Kong

Dow Jones
·
30 Jun

China Traditional Chinese Medicine Holdings Co. Announces NMPA Acceptance of New Drug Application for Yushuda Tablets, Initiating Regulatory Review

Reuters
·
25 Jun

Sinopharm Group Co. Ltd. Conducted Annual General Meeting

Reuters
·
12 Jun

BRIEF-Sinopharm Group Appoints Hu Ligang As A Vice President

Reuters
·
09 Jun

Sinopharm Group Announces Management Changes: Mr. Hu Ligang Resigns as Non-Executive Director, Mr. Ma Yue Proposed as Successor

Reuters
·
09 Jun

Sinopharm's Q1 Profit Jumps

MT Newswires Live
·
28 Apr

BUZZ-China's Sinopharm rises most in over six months as quarterly profit climbs

Reuters
·
28 Apr

BRIEF-Sinopharm Group Posts Qtrly Net Profit Attributable RMB328 Million For Sinopharm Accord

Reuters
·
24 Apr

DIARY-Hong Kong corporate earnings week ahead

Reuters
·
18 Apr

Nomura Adjusts Sinopharm Group's Price Target to HK$23.40 From HK$25.09, Keeps at Buy

MT Newswires Live
·
25 Mar